标题
Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CANCER
Volume 185, Issue -, Pages 94-104
出版商
Elsevier BV
发表日期
2023-02-25
DOI
10.1016/j.ejca.2023.02.019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010
- (2023) Carolyn M. Larsen et al. JAMA Network Open
- Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
- (2022) Xin-Ru Li et al. Journal of Ovarian Research
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
- (2022) Alexander R Lyon et al. EUROPEAN HEART JOURNAL
- Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
- (2022) Carmelita Abrahams et al. Lipids in Health and Disease
- Mechanisms of anthracycline-mediated cardiotoxicity and preventative strategies in women with breast cancer
- (2021) Sonu S. Varghese et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
- (2020) Paweł Sobczuk et al. HEART FAILURE REVIEWS
- Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas
- (2020) William D. Tap et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epigenetics changes associated with anthracyclines induced cardiotoxicity
- (2020) Marwa Tantawy et al. CTS-Clinical and Translational Science
- The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association ( HFA ), the European Association of Cardiovascular Imaging ( EACVI ) and the Cardio‐Oncology Council of the European Society of Cardiology ( ESC )
- (2020) Jelena Čelutkienė et al. EUROPEAN JOURNAL OF HEART FAILURE
- High cumulative doxorubicin dose for advanced soft tissue sarcoma
- (2020) Zhichao Tian et al. BMC CANCER
- Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date
- (2019) Lee D Cranmer OncoTargets and Therapy
- A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma
- (2019) Brian A. Van Tine et al. Cancer Medicine
- Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta‐analysis
- (2019) Lars Michel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients
- (2018) Kelly Liesse et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
- (2017) Patrick Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients
- (2016) Markus K. Schuler et al. BMC CANCER
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model
- (2016) Nicole E. Frank et al. INVESTIGATIONAL NEW DRUGS
- Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
- (2016) Barbara L. Asselin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study
- (2015) Alex Rabinovich et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma
- (2015) Sant P. Chawla et al. JAMA Oncology
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer
- (2013) Carlo Palmieri et al. Clinical Breast Cancer
- Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: Is it necessary?
- (2013) Sarah E. Gill et al. GYNECOLOGIC ONCOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
- (2009) Anastasia Constantinidou et al. EUROPEAN JOURNAL OF CANCER
- Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin
- (2008) D. Ravel et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Martee L. Hensley et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now